QA: Decoy Therapeutics Inc in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001615219_2018_Decoy_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001615219, Decoy Therapeutics Inc

  xvar xval
0 AssetsCurrent 34,535,137
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 331,040
3 remainder_Assets 126,595
4 LiabilitiesCurrent 5,847,670
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 39,214
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 18,503,684
9 ResearchAndDevelopmentExpense 16,989,911
10 remainder_Expenses 506,530
11 remainder_Revenues 1,274,499
12 remainder_NetIncome 291,964
13 remainder_ComprehensiveNetIncome 367
  yvar yval
0 Assets 34,992,772
1 Liabilities 5,886,884
2 Expenses 36,000,125
3 Revenues 1,274,499
4 StockholdersEquity 29,105,888
5 NetIncome -34,433,662
6 ComprehensiveNetIncome -34,433,478
7 BaseVar 39,223,306
8 EconomicCapitalRatiobeforeLimitedLiability 1.42
9 EconomicCapitalRatio 2.62

Edgar->Model Mapping

Feature Distribution